Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
作者
Amrita Krishnan,Monique C. Minnema,Jesus G. Berdeja,Albert Oriol,Niels W.C.J. van de Donk,Paula Rodriguez-Otero,Elham Askari,Maria-Victoria Mateos,Luciano J. Costa,Raluca Verona,Xuewen Ma,Suzette Girgis,Shiyi Yang,Brandi Hilder,Jeffery S. Russell,Jenna D. Goldberg,Ajai Chari